Neutropenic fever is a common complication for cancer patients undergoing chemotherapy. In fact, one out of every 29 chemotherapy-treated patients is hospitalized, with a startling mortality rate of 7-9.5%. Fevers can come on suddenly and…
Continue Reading
A pioneering proton radiotherapy approach is employed in Switzerland to treat oesophageal cancer, with a 67-year-old patient being the first beneficiary. This innovative treatment aims to reduce lung complications and is part of a…
Continue Reading
More than 1,300 oncology drugs are in the development pipeline, waiting to potentially embark on the long journey toward their commercial debut. This journey is usually an arduous one, made even more difficult by…
Continue Reading
Human Papilloma Virus (HPV)-associated oropharyngeal squamous cell cancer (OPSCC) represents an OPSCC subgroup with an overall good prognosis with a rising incidence in Western countries. Multiple lines of evidence suggest that HPV-associated tumors are…
Continue Reading
By Shania Kennedy
August 18, 2023 – In a study recently published in JAMA Network Open, researchers have externally validated a machine learning (ML) model designed to predict six-month mortality risk for patients with advanced cancer…
Continue Reading
Remote monitoring is fast becoming central to the health service’s hopes of squaring the circle of increased demand for healthcare and staff shortages. For health tech company Entia, offering remote monitoring for cancer patients…
Continue Reading
By Sara Heath
August 17, 2023 – Hispanic or Latina women get diagnosed with breast cancer at a younger age than their counterparts of other races, but that’s not because of more habitual breast cancer screening…
Continue Reading
iCAD and Google Health are intensifying their partnership to integrate advanced AI technology into the ProFound Breast Health Suite for 2D Mammography. This collaboration aims to facilitate independent reading for breast cancer screening worldwide,…
Continue Reading
Telehealth and medical transportation company DocGo announced it is partnering with New York-based not-for-profit health insurer EmblemHealth to provide patients with in-home services, such as transitional care management, following discharge from the hospital. Emblem and…
Continue Reading
By Shania Kennedy
August 16, 2023 – Researchers have developed a deep learning (DL) model capable of predicting cancer-related protein fragments that may elicit an immune response, which may aid the advancement of personalized cancer therapies.
The…
